同期狭窄成形术联合腔道对合金属支架治疗Roux-en-Y胃旁路术后胃空肠狭窄
本研究为单中心回顾性队列,纳入25例Roux-en-Y胃旁路术后胃空肠狭窄接受腔道对合金属支架(LAMS)的患者,其中7例同期行内镜下狭窄成形术。整体短期和长期临床成功率分别为88.0%和64.0%,同期狭窄成形组长期成功率为71.4%,LAMS-only组为61.1%(p=0.985)。
要点
- LAMS治疗胃空肠狭窄短期成功率高,整体短期临床成功率为88.0%。
- 同期狭窄成形组既往≥3次球囊扩张比例更高(85.7% vs 16.7%,p=0.006)。
- 支架移位仅见于LAMS-only组(16.7% vs 0%,p=0.641)。
核心结论
- LAMS是治疗Roux-en-Y胃旁路术后胃空肠狭窄安全有效的方法,短期成功率高。
- 对多次既往扩张或复杂纤维性狭窄患者,同期狭窄成形术技术上可行,可能减少支架移位并改善耐久性,但需进一步研究。
研究设计与样本
- 单中心回顾性队列研究,纳入2020年1月至2025年5月接受LAMS置入的胃空肠狭窄患者25例。
- 按是否在支架置入时同期行内镜下狭窄成形术分组,比较临床结局。
主要发现
- 25例患者平均年龄46.8±12.9岁,女性占76%,7例(28%)行同期狭窄成形术。
- 整体短期(≤30天)和长期(>90天)临床成功率分别为88.0%和64.0%。
- 长期成功率在狭窄成形组为71.4%,LAMS-only组为61.1%(p=0.985)。
- 支架移位3例(12.0%),均发生在LAMS-only组(0% vs 16.7%,p=0.641)。
- 狭窄成形组平均支架留置时间较短(52.6 vs 90.4天,p=0.896),且既往≥3次球囊扩张比例更高(85.7% vs 16.7%,p=0.006)。
关键数值与推荐
- 临床成功定义为症状缓解且无需再次干预。
- 主要结局为长期临床成功(>90天),次要结局包括短期临床成功(≤30天)、支架留置时间、手术时间、支架移位和不良事件。
临床怎么用
- LAMS可作为胃空肠狭窄的治疗选择,尤其适用于短期症状缓解。
- 对既往多次球囊扩张或复杂纤维性狭窄患者,可考虑同期狭窄成形术以减少支架移位。
局限性
- 单中心回顾性设计,样本量较小(25例),同期狭窄成形组仅7例。
- 部分比较无统计学显著性,结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gastrojejunal (GJ) anastomotic strictures are a challenging complication following Roux-en-Y gastric bypass (RYGB) and may be refractory to conventional balloon dilation. Lumen-apposing metal stents (LAMS) provide anchored, wide-caliber support that may treat strictures, yet long-term outcomes remain variable, and stent migration is a concern. This study evaluates the clinical effectiveness and safety of LAMS with or without concurrent endoscopic stricturoplasty in patients with GJ strictures. METHODS: We conducted a single-center retrospective cohort study of patients with GJ strictures who underwent LAMS placement between January 2020 and May 2025. Patients were stratified by whether concurrent endoscopic stricturoplasty was performed at the time of stent placement. Clinical success was defined as symptom resolution without need for reintervention. The primary outcome was long-term clinical success (> 90 days). Secondary outcomes included short-term clinical success (≤ 30 days), stent dwell time, procedure duration, stent migration, and adverse events. RESULTS: Twenty-five patients were included (mean age 46.8 ± 12.9 years; 76% female), with 7 (28%) undergoing concurrent stricturoplasty. The overall cohort short-term and long-term clinical success rates were 88.0% and 64.0% respectively. Long-term success was 71.4% in the stricturoplasty group vs. 61.1% in the LAMS-only group (p = 0.985). Stent migration occurred in 3 patients (12.0%), all in the LAMS-only group (0% vs. 16.7%, p = 0.641). Mean stent dwell time was shorter in the stricturoplasty group (52.6 vs. 90.4 days, p = 0.896), and the stricturoplasty group had significantly higher rates of prior ≥ 3 balloon dilations (85.7% vs. 16.7%, p = 0.006), suggesting a more refractory phenotype. CONCLUSIONS: LAMS is a safe and effective treatment for GJ strictures after RYGB, with high short-term success. In patients with multiple prior dilations or complex fibrotic strictures, concurrent stricturoplasty appears to be a technically feasible adjunct that may reduce stent migration and improve durability. These trends support further investigation.
引用
- Zhu X, Mocanu V, Kachornvitaya P, et al. Concurrent stricturoplasty with lumen-apposing metal stents for gastrojejunal strictures after Roux-en-Y gastric bypass. Surg Endosc. 2026. PMID: 42257964. doi:10.1007/s00464-026-12844-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。